AstraZeneca's COVID vaccine suffers a setback in nasal spray trial

AstraZeneca's COVID vaccine suffers a setback in nasal spray trial Antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in the first of usually three phases of clinical testing, the University of Oxford said in a statement. https://ift.tt/iHuKFeT

India registers 1,957 new COVID-19 cases, active cases decline to 27,374

India registers 1,957 new COVID-19 cases, active cases decline to 27,374 2,654 patients have recovered in the last 24 hours. The weekly positivity rate in the country currently stands at 1.21 per cent and the daily positivity rate is reported to be 0.71 per cent. https://ift.tt/iHuKFeT

In a 1st, Amit Shah to launch MBBS course in Hindi

In a 1st, Amit Shah to launch MBBS course in Hindi Home minister Amit Shah will launch medical education in Hindi in Madhya Pradesh by releasing translated MBBS first-year books in Bhopal on October 16. https://ift.tt/iHuKFeT